Study shows that an FDA-cleared biomarker can help to reduce ADHD overdiagnosis

“Because underdiagnosis can lead to poor future outcomes in children with ADHD, a lot of effort has gone into developing assessment tests that are sensitive in detecting ADHD-like symptoms,” said Dr. Snyder. “NEBA can complement existing tests by ...



from Meta Search Alerts http://ift.tt/1EuL8y9

via IFTTT